Recent Quotes
My Watchlist
Indicators
Local Stocks
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

IM Cannabis Corp (CSE: IMCC )

2.960 +0.310 (+11.70%)
Official Closing Price Updated: 3:42 PM EST, Nov 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about IM Cannabis Corp

Canopy Growth And Other Top Cannabis Companies To Report Earnings: Will Results Get Pot Stocks On Track Following Post-Election Dip?
Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) will report the second quarter of fiscal year 2025 ended Sept. 30, before financial markets open on Friday, Nov. 8, 2024. IM Cannabis Corp. (CSE:... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
The Ever-Evolving Cannabis Industry: These Are Latest Leadership Changes You Should Know About
The U.S. Hemp Roundtable made headlines in early September as its board of directors welcomed two distinguished leaders from the hemp beverage sector to its officer ranks. New York's chief equity... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
IM Cannabis' $1.6M Non-Brokered Private Placement Offering, Here's What Investors Need To Know
Medical cannabis company with operations in Israel and Germany, IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC), intends to undertake a non-brokered private placement offering of up to $1,613,000 through... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
How Cannabis Legalization In Germany Boosted This Company's Revenue, Will Spain's Medical Marijuana Framework Do The Same?
Spain's Ministry of Health revealed this week a draft royal decree for public consultation, outlining the suggested regulations for prescribing cannabis-based medications, reported Business of... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
IM Cannabis Soars: German Sales Surge 200% In First 3 Months Post-Legalization, Q2 Revenue Up 12% YoY
The company, announced its financial results Wednesday for the second quarter ended June 30, 2024, revealing a 12% year-over-year increase in revenue to CA$14.8 million in the second quarter of 2023.... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
IM Cannabis, Organigram And Other Hot Cannabis Stocks Soon To Report Earnings, What Investors Need To Know Now
Medical cannabis company IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC), with operations in Israel and Germany, will report operational and financial results for the second quarter of 2024 ended June 30,... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
IM Cannabis Announces Major Share Consolidation Plan: What Investors Need To Know
IM Cannabis announces a share consolidation effective July 12, aiming to enhance marketability and streamline shares. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Global Weed Business: Flora Buys Australian Vaporizers As IM Cannabis Doubles Down On Germany
Lifeist Wellness Inc. (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF) said on Wednesday the sale of Australian Vaporizers Pty Ltd., its wholly owned Australian subsidiary to Flora Growth Corp. (NASDAQ:... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
IM Cannabis Doubles Down On Germany Following Legalization Policy Change, Reports YoY Drop In Q1 Gross Profit And Revenue
IM Cannabis reported a 13% sequential increase in revenue for the three months ended March 31, 2024, hitting CA$10.7 million ($7.8 million). That is, however, a 4% decrease compared to the same quarter... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
IM Cannabis' Q4 Revenue: Gross Profit Drops Due To Negative Impact Of Israel-Hamas War, Sees Germany As Growth Opportunity
IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) announced on Thursday its financial and operational results for the year ended Dec. 2023. The Toronto-headquartered medical cannabis company with a focus on... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
IM Cannabis Stock Drops On Q2 Earnings, CEO Touts Strategic Decisions That Led To 'Sustainable Profitability'
IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) reported its second-quarter financial results on Tuesday for the period ending June 30, 2023. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
IM Cannabis To Buy Jerusalem-Based Medical Marijuana Pharmacy For $4.9M In Cash And Stock
IM Cannabis Corp. (CSE:IMCC), (NASDAQ: 
Via Benzinga
Topics Cannabis
Exposures Cannabis
IM Cannabis To Debut WAGNERS Brand In Israel After Receiving Regulatory Approval
IM Cannabis Corp. (CSE:IMCC) (NASDAQ: 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.